amyloid P-IN-1 |
Katalog-Nr.GC33160 |
Amyloid P-IN-1 wird zur Erforschung von Krankheiten oder StÖrungen verwendet, bei denen die Serum-Amyloid-P-Komponente (SAP) erschÖpft ist, einschließlich Amyloidose, Alzheimer-Krankheit, Diabetes mellitus Typ 2 und Osteoarthritis.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1819986-22-5
Sample solution is provided at 25 µL, 10mM.
pharmaceutical compositions comprising the same and the use of the same for treatment of diseases or disorders wherein depletion of serum amyloid P component (SAP) would be beneficial, including amyloidosis, Alzheimer's disease, type 2 diabetes mellitus and osteoarthritis.
[1]. PCT Int. Appl. (2015), WO 2015165833 A1 20151105. [2]. U.S. Pat. Appl. Publ. (2016), US 20160081983 A1 20160324.
Average Rating: 5
(Based on Reviews and 27 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *